动态磁敏感灌注MRI鉴别胶质瘤II级与III级:一项Meta分析
本Meta分析纳入28项研究共727例患者,评估DSC灌注MRI相对最大CBV鉴别胶质瘤WHO II级与III级的诊断准确性。II级与III级间相对最大CBV平均差为1.76(95%CI 1.27-2.24;P<.001),个体数据(190例)AUC为0.77,最佳截断值2.02;星形细胞瘤AUC升至0.86,少突胶质细胞瘤降至0.61。
要点
- 胶质瘤III级相对最大CBV高于II级,平均差1.76(95%CI 1.27-2.24;P<.001)。
- 个体数据鉴别II级与III级AUC为0.77,最佳截断值2.02。
- 星形细胞瘤AUC 0.86,少突胶质细胞瘤AUC仅0.61。
核心结论
- 胶质瘤III级相对最大CBV高于II级;全部患者及星形细胞瘤诊断准确性高,但鉴别少突胶质细胞瘤II级与III级时准确性明显降低。
研究设计与样本
- 系统检索PubMed/MEDLINE、Embase、Web of Science和ClinicalTrials.gov的Meta分析,纳入28项研究共727例经神经病理确诊的WHO II级和III级胶质瘤患者,其中10项研究190例有个体数据。
诊断标准与关键数值
- 相对最大CBV鉴别II级与III级胶质瘤(n=727)平均差1.76(95%CI 1.27-2.24;P<.001);个体数据(n=190)最佳截断值2.02时AUC为0.77,星形细胞瘤AUC 0.86,少突胶质细胞瘤AUC 0.61。
局限性
- 纳入研究间存在显著异质性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND: DSC perfusion has been evaluated in the discrimination between low-grade and high-grade glioma but the diagnostic potential to discriminate beween glioma grades II and III remains unclear.
PURPOSE: Our aim was to evaluate the diagnostic accuracy of relative maximal CBV from DSC perfusion MR imaging to discriminate glioma grades II and III.
DATA SOURCES: A systematic literature search was performed in PubMed/MEDLINE, Embase, Web of Science, and ClinicalTrials.gov.
STUDY SELECTION: Eligible studies reported on patients evaluated with relative maximal CBV derived from DSC with a confirmed neuropathologic diagnosis of glioma World Health Organization grades II and III. Studies reporting on mean or individual patient data were considered for inclusion.
DATA ANALYSIS: Data were analyzed by using inverse variance with the random-effects model and receiver operating characteristic curves describing optimal cutoffs and areas under the curve. Bivariate diagnostic random-effects meta-analysis was used to calculate diagnostic accuracy.
DATA SYNTHESIS: Twenty-eight studies evaluating 727 individuals were included in the meta-analysis. Individual data were available from 10 studies comprising 190 individuals. The mean difference of relative maximal CBV between glioma grades II and III (n = 727) was 1.76 (95% CI, 1.27-2.24; P < .001). Individual patient data (n = 190) had an area under the curve of 0.77 for discriminating glioma grades II and III at an optimal cutoff of 2.02. When we analyzed astrocytomas separately, the area under the curve increased to 0.86 but decreased to 0.61 when we analyzed oligodendrogliomas.
LIMITATIONS: A substantial heterogeneity was found among included studies.
CONCLUSIONS: Glioma grade III had higher relative maximal CBV compared with glioma grade II. A high diagnostic accuracy was found for all patients and astrocytomas; however, the diagnostic accuracy was substantially reduced when discriminating oligodendroglioma grades II and III.
引用
- Delgado AF, Delgado AF. Discrimination between Glioma Grades II and III Using Dynamic Susceptibility Perfusion MRI: A Meta-Analysis. AJNR Am J Neuroradiol. 2017. PMID: 28522666. doi:10.3174/ajnr.A5218
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。